David Domzalski's Net Worth

$709 Thousand

Estimate Recalculated Apr 3, 2024 04:14PM EST

Who is David Domzalski?

David Domzalski does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Foamix Pharmaceuticals Ltd., and VYNE Therapeutics Inc..

SEC CIK

David Domzalski's CIK is 0001727794

Past Insider Trading and Trends

2023 was David Domzalski's most active year for acquiring shares with 4 total transactions. David Domzalski's most active month to acquire stocks was the month of December. 2018 was David Domzalski's most active year for disposing of shares, totalling 13 transactions. David Domzalski's most active month to dispose stocks was the month of February. 2019 saw David Domzalski paying a total of $665,892.49 for 254,117 shares, this is the most they've acquired in one year. In 2018 David Domzalski cashed out on 49,150 shares for a total of $101,230.84, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Foamix Pharmaceuticals Ltd. No price found

CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-324.03K
—
—
0
Mar 9
Form 4
+1.47%
4.71K
$2.68
$12,597.64
324.03K
Mar 2
Form 4
+47.78%
103.25K
—
—
319.32K
Feb 24
Form 4
-1.26%
-2.75K
$3.28
-$9,023.28
216.07K
Dec 31
Form 4
+4.71%
9.84K
$2.16
$21,248.88
218.83K
Nov 29
Form 4
-1.07%
-2.26K
$3.07
-$6,925.92
208.98K
Sep 30
Form 4
-1.56%
-3.35K
$2.35
-$7,884.25
211.24K
Jul 1
Form 4
-2.32%
-5.10K
$3.75
-$19,110.00
214.59K
Apr 1
Form 4
+50.05%
73.28K
—
—
219.69K
Jan 1
Form 4
-0.05%
-68.00
$4.05
-$275.40
146.41K
Dec 3
Form 4
-3.32%
-5.04K
$3.90
-$19,640.40
146.48K
Nov 19
Form 4
-1.34%
-2.06K
$4.58
-$9,443.96
151.51K
Nov 8
Form 4
-0.39%
-601.00
$5.81
-$3,491.81
153.57K
Oct 1
Form 4
-0.04%
-67.00
$5.67
-$379.89
154.18K
Sep 4
Form 4
-5.07%
-8.24K
$5.68
-$46,791.84
154.24K
Aug 8
Form 4
-0.37%
-602.00
$5.10
-$3,070.20
162.48K
Jul 2
Form 4
-0.04%
-67.00
$5.26
-$352.42
163.08K
Jun 1
Form 4
-12.54%
-23.40K
—
—
163.15K
May 8
Form 4
-0.43%
-602.00
$5.08
-$3,058.16
139.75K
Apr 2
Form 4
-0.05%
-66.00
$5.95
-$392.70
140.36K
Mar 1
Form 4
+2.59%
3.55K
$5.98
-$14,334.06
140.42K
Jan 1 - Jan 2
Form 3
—
0
—
—
0
No matching records found

VYNE Therapeutics Inc. (VYNE) Snapshot price: $2.11

PRESIDENT AND CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-0.20%
-1.00K
$3.08
-$3,092.32
494.16K
Apr 1
Form 4
+82.60%
224K
$2.28
-$2,289.12
495.16K
Jan 1 - Jan 2
Form 4
+487.35%
225K
—
—
271.17K
Dec 13
Form 4
+5.20%
2.28K
$2.81
$6,426.03
46.17K
Nov 30
Form 4
-16.30%
-8.55K
$3.83
-$32,742.67
43.88K
Oct 2
Form 4
-1.84%
-981.00
$4.10
-$4,022.10
52.43K
Jun 30
Form 4
+5.46%
2.77K
$3.46
$9,560.13
53.41K
May 31
Form 4
-5.12%
-2.73K
$3.08
-$8,420.72
50.65K
Mar 31
Form 4
-0.99%
-10.69K
$0.15
-$1,602.75
1.06M
Dec 31
Form 4
+3.34%
34.7K
$0.20
$6,861.18
1.07M
Nov 30
Form 4
-1.02%
-10.68K
$0.22
-$2,382.31
1.04M
Sep 30
Form 4
-1.01%
-10.68K
$0.39
-$4,155.69
1.05M
Jun 30
Form 4
+1.13%
11.89K
$0.35
$4,116.47
1.06M
May 31
Form 3
—
0
—
—
0
No matching records found